CD4 and cancer: One of the first attempts to distinguish between pTreg conversion and tTreg expansion in cancer was pursued by Bui and colleagues who adoptively transferred CD4+CD25+ cells, mixed at 1:10 ratio with CD25-depleted Thy1.1-congenic splenocytes, into immunodeficient mice bearing a progressive sarcoma (70).